This large population-based study identified key risk and protective factors for long COVID among patients with NIU. Findings suggest that systemic corticosteroid-induced immune dysregulation may increase vulnerability to long COVID in individuals with severe uveitis.
Kumar et al. (Tue,) studied this question.